Formulation Approaches to Overcome Biopharmaceutical Limitations of Inhaled Peptides/Proteins

E-ISSN： 1873-4286|21|27|3867-3874

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.27, 2015-01, pp. : 3867-3874

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biopharmaceutical Powders Particle Formation and Formulation Considerations

Current Pharmaceutical Biotechnology, Vol. 1, Iss. 3, 2000-11 ,pp. : 283-302

Bentham Science Publishers

Access to resources Recommend Favorite

Approaches to Improve Cellular Retention of Radiohalogen Labels Delivered by Internalising Tumour-Targeting Proteins and Peptides

Current Medicinal Chemistry, Vol. 10, Iss. 22, 2003-11 ,pp. : 2447-2460

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmaceutical Formulation Development of Peptides and ProteinsSven Frokjaer, Lars Hovgaard, Taylor & Francis, Andover, UK, 2000, 238 pages, ISBN 0-748-40745-6

By Lee G.

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 50, Iss. 2, 2000-09 ,pp. : 329-329

Elsevier

Access to resources Recommend Favorite

Inhaled Formulation Design for the Treatment of Lung Infections

Current Pharmaceutical Design, Vol. 21, Iss. 27, 2015-01 ,pp. : 3875-3901

Bentham Science Publishers

Access to resources Recommend Favorite

Formulation and Biopharmaceutical Evaluation of Osmotic Matrix Tablets of Diclofenac Sodium

By Rani Meena Surana Rahul Sankar C. Mishra B.

Drug Delivery, Vol. 11, Iss. 4, 2004-01 ,pp. : 263-270

Informa Healthcare

Access to resources Recommend Favorite